Menu

Helping the CDC Chronic Disease Center Roll out New Metrics

Image for Helping the CDC Chronic Disease Center Roll out New Metrics

PHIL facilitated a working group across six states for the Center for Disease Control’s National Association of Chronic Disease Directors. States previously reported to the CDC on 200 different measures, including many for which data were difficult to access. This new PHIL-supported effort enabled State Chronic Disease Directors to create new criteria for Chronic Disease Funding performance measures that better reflect the reality of reporting states. This PHIL-supported effort will streamline reporting and enable more effective demonstration of meaningful impact.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org